IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Eagle Pharmaceuticals Inc (EGRX)

Q2 2026 vs Q3 2026

Comparing institutional holders between quarters

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Stanley-Laman Group, Ltd.
UNCHANGED
Shares12,000 from 12,000
Change0 (0%)
Value$11.4K (+$3.4K)
Filed 2026-10-20
Archer Investment Corp
UNCHANGED
Shares350 from 350
Change0 (0%)
Value$333 (+$98)
Filed 2026-11-05
Status
Stanley-Laman Group, Ltd.
UNCHANGED12,00012,00000%$8.0K$11.4K+$3.4K2026-10-20
Archer Investment Corp
UNCHANGED35035000%$235$333+$982026-11-05
Showing 2 of 2 institutions